TP53


Also found in: Dictionary, Acronyms, Wikipedia.

TP53

(tē′pē′fĭf′tē-thrē′)
n.
See p53.
References in periodicals archive ?
About 65 percent of patients who carried high-risk TP53 variant in this study had the hypodiploid subtype of ALL.
113-115) Of these genes, TERT, CDKN2A/2B, EGFR, and TP53 are well-characterized recurrently altered genes in sporadic IGs.
We used our clinical and research experience from studying patients with Li-Fraumeni Syndrome to try to understand if elephant TP53 could be playing a role in protecting elephants from cancer.
In contrast to TP53 mutations, the adverse effect of RAS mutations on survival and risk of relapse was evident only in reduced-intensity conditioning.
She was progressing on goserelin and capecitabine at the time of first blood sample in May 2013, which had amplified ERBB2, TP53 mutation (VAF = 6.
Following treatment with different concentrations of dioscin for 24 h, the protein expression levels of TP53, BAX, BCL2 and CASP3 (P17) were detected by Western blotting.
Hainaut, "Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases," Cancer Letters, vol.
The TP53 gene product is a nuclear phosphoprotein that is expressed at low levels in most normal tissues and plays a key role in the control of cell cycle progression, genome stability and apoptosis.
Caused by mutations in the tumor suppressor gene TP53, individuals with the syndrome have a 90% risk of cancer by age 60 years.
FISH analysis was performed using the following probes from Abbott Molecular (Des Plaines, Illinois 60018, USA): The Vysis C-MYC /CEP 8 Probes and TP53/CEP17 Probes, and showed loss of one copy of TP53 in 65 of 150 nuclei examined and more than three copies of 8q24 ( C-MYC ) in 20 of 150 nuclei [Figure 2]a and b.
Rhabdomyosarcoma-associated renal cell carcinoma: A link with constitutional TP53 mutation.